Fig. 5From: Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysisBayesian ranking probabilities of comparable treatments for each adverse event. Profiles indicate the probability of each comparable treatment being ranked from worst to best on adverse events. Ranking sources are described in Additional file 1: table S5 (ST = systemic treatment, pfu = plaque-forming units)Back to article page